Foot & Mouth Disease Vaccine Market Size Worth $3.0 Billion By 2025

The global foot and mouth disease (FMD) vaccine market is expected to reach USD 3.0 billion by 2025, according to a new report by Grand View Research, Inc. An increase in the incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for a lower time period propels the repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as a change in food preferences owing to changing lifestyles coupled with a growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

 To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/foot-mouth-disease-fmd-vaccine-market

Further Key Findings From the Report:

• Conventional vaccines emerged as the largest segment because of increasing approvals of vaccines and higher efficacy

• The cattle segment accounted for the largest share in the animal type segment owing to increase in domestic livestock population and number of outbreaks

• Sheep and Goat segment is expected to grow at the fastest rate over the forecast period owing to the rising incidence of FMD infection in sheep population and the need for reducing the slaughter of infected animals.

• Asia Pacific dominated the market with the largest share in 2016. The rise in the incidence of FMD and an increase in demand for livestock products are facilitating the dominance of the region during the forecast period.

• Key players including Agrovet Co.; Biogénesis Bago; Empresa Colombiana de Productos Veterinarios S.A. Vecol S.A.; FGBI - Federal Centre for Animal Health; Indian Immunologicals Limited; Merial (France); Veterinary Serum and Vaccine Research Institute; FMD Center; and Limor de Colombia are leading the global FMD vaccine market.

Grand View Research has segmented the global foot and mouth disease vaccine market based on technique, animal type, and region:

Technique Outlook (Revenue, USD Million, 2014 - 2025)

• Conventional vaccines

  • Aluminum hydroxide/Saponin-based vaccines

  • Oil-based vaccines

• Emergency vaccines

Animal Type Outlook (Revenue, USD Million, 2014 - 2025)

• Cattle

• Sheep and Goat

• Pigs

• Others (antelope, deer, bison, camelids)

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America

• Europe

• Asia Pacific

  • India

  • China

  • Japan

  • Malaysia

  • South Korea

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

  • South Africa

  • Nigeria

  • Saudi Arabia